BD1393848
Pravastatin , 98+% , 81093-37-0
| Pack Size | Price | Stock | Quantity |
| 25mg | RMB1389.60 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 171.2-173 °C |
| Boiling point: | 634.5±55.0 °C(Predicted) |
| Density | 1.21±0.1 g/cm3(Predicted) |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | H2O: 19 mg/mL |
| form | powder |
| pka | 4.31±0.10(Predicted) |
| color | white |
| InChIKey | VWBQYTRBTXKKOG-SYYCFNTLNA-M |
| SMILES | C12=C[C@@H](O)C[C@H](OC([C@@H](C)CC)=O)[C@]1([H])[C@H]([C@@H](C)C=C2)CC[C@@H](O)C[C@@H](O)CC(=O)[O-].[Na+] |&1:2,5,8,13,15,16,22,25,r| |
| CAS DataBase Reference | 81093-37-0(CAS DataBase Reference) |
| EPA Substance Registry System | 1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-.beta.,.delta.,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, (.beta.R,.delta,R,1S,2S,6S,8S,8aR)- (81093-37-0) |
Description and Uses
Pravastatin is the third HMG-CoA reductase inhibitor introduced for the treatment of atherosclerosis. Compared with lovastatin and simvastatin launched earlier, pravastatin is equipotent as an HMG-CoA reductase inhibitor in vitro, yet it is reported to be more tissue-selective.
anti-hyperlipoproteinemic, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor
Safety
| Symbol(GHS) |   GHS08,GHS09 |
| Signal word | Danger |
| Hazard statements | H350-H360--H410 |
| Precautionary statements | P273-P260-P314-P501 |
| Hazard Codes | F,C |
| Risk Statements | 11-34 |
| Safety Statements | 16-26-36/37/39-45 |
| WGK Germany | 2 |
| RTECS | QJ7185000 |
| Hazardous Substances Data | 81093-37-0(Hazardous Substances Data) |
